 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/14/2019 |
$0.41 |
$0.43 |
$0.37 |
$0.40 |
339.30K | | 02/15/2019 |
$0.38 |
$0.41 |
$0.38 |
$0.39 |
116.50K | | 02/19/2019 |
$0.38 |
$0.40 |
$0.38 |
$0.39 |
54.10K | | 02/20/2019 |
$0.90 |
$0.97 |
$0.51 |
$0.51 |
25.94M | | 02/21/2019 |
$0.58 |
$0.60 |
$0.43 |
$0.48 |
7.14M |
|
|
| ARCA biopharma is a biopharmaceutical company focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s key product candidate, Gencaro™ (bucindolol hydrochloride), is an investigational pharmacological beta-blocker and mild vasodilator that Co. is developing for the potential treatment of patients with chronic heart failure with reduced left ventricular ejection fraction, who also have atrial fibrillation (AF), or at risk of developing AF. Co. also has pharmacogenetic and other patent rights to drug candidates that have potential indications in cardiovascular disease, oncology and other therapeutic areas. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on February 14, 2019, ABIO opened at $0.41, traded as high as $0.43 and as low as $0.37, and closed at $0.40. Trading volume was a total of 339.30K shares. On February 15, 2019, ABIO opened at $0.38, traded as high as $0.41 and as low as $0.38, and closed at $0.39. Trading volume was a total of 116.50K shares. On February 19, 2019, ABIO opened at $0.38, traded as high as $0.40 and as low as $0.38, and closed at $0.39. Trading volume was a total of 54.10K shares. On February 20, 2019, ABIO opened at $0.90, traded as high as $0.97 and as low as $0.51, and closed at $0.51. Trading volume was a total of 25.94M shares. On February 21, 2019, ABIO opened at $0.58, traded as high as $0.60 and as low as $0.43, and closed at $0.48. Trading volume was a total of 7.14M shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/23/2009 |
|
| End date: |
02/21/2019 |
|
| Start price/share: |
$226.80 |
|
| End price/share: |
$0.48 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.79% |
|
| Average Annual Total Return: |
-45.98% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$21.16 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/14/2019 | $0.40 | | 02/15/2019 | $0.39 | | 02/19/2019 | $0.39 | | 02/20/2019 | $0.51 | | 02/21/2019 | $0.48 |
|
|
